Member login

Discover the benefits of BIA membership

Member Benefits

Scroll for more

Join the #BIGIMPACT revolution

13 Jul 23

Event

Join us at the BIA Summer Party 2023

12 May 23

BIA Blog

UK biotech shows progress on diversity - and has more to do

05 Apr 23

PDF

Rare insights: examining the social values of treating rare diseases

26 May 23

Press Release

BIA welcomes Chancellor’s life sciences growth package

The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation.

Explore opportunities to influence, connect and save with the BIA.

Influence

policymakers, ensuring your voice is heard on matters that are critical to the success of your organisation

Connect

with the UK ecosystem through industry-leading events, expert committees and overseas missions

Save

money with the BIA Business Solutions purchasing programme, helping your business grow cost-effectively

Biotech and life sciences news and insights

View all news

Press Releases

15 May 23

Press Release

BIA launches #BIGIMPACT campaign to encourage talent with digital skills to start a career in biotech

The BioIndustry Association (BIA) is launching #BIGIMPACT, a new campaign encouraging people with digital and data-driven skills to consider a career in the biotech industry. The campaign shines a spotlight on new career pathways that are possible in biotech, for example, an AI engineer, bioinformatician or data analyst.

24 Apr 23

Press Release

Venture deals continue to flow for UK biotech under dark clouds

The first quarter of 2023 has seen deal flow continue for the UK’s innovative life science and biotech companies at all stages of development, new data from the UK BioIndustry Association and Clarivate shows. As global macro-economic headwinds, suppressed public markets and political uncertainty weighed on investor confidence, venture investment remained steady, with private UK biotechs securing £258 million across 20 deals, with an average deal size of £13 million.

05 Apr 23

Press Release

BIA calls on NICE to refresh evidence informing how rare disease medicines are evaluated and paid for

The UK BioIndustry Association has today published research suggesting the UK’s medicines evaluation body is basing its methods and processes for evaluating medicines for rare diseases on outdated evidence. Rare insights: examining the social values of treating rare diseases presents the findings of primary research into public opinion on how treatments for rare diseases should be evaluated and funded within the NHS.

Member News

BIA blog

22 May 23

BIA Blog

CEO Update - 22 May 2023

On Thursday I will be attending the bi-annual UK Life Science Council, the set piece meeting of the UK life science industry with the UK government. Thanks to months-long backroom work, by the BIA team and civil servants, I think the scene is set for a productive discussion on the Scale Up finance agenda, what we need to do to get clinical trials going again in the UK and how we can support the development of a skilled workforce in life science.

Latest resources

Here's a selection of featured BIA resources. Explore our Resources Hub